Novo Nordisk
NVO
#89
Rank
โ‚น19.064 T
Marketcap
โ‚น4,302
Share price
1.28%
Change (1 day)
-25.93%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚น2.254 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น51.37 Billion. In 2025 the company made an earning of โ‚น2.005 Trillion, an increase over its 2024 earnings that were of โ‚น1.887 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.254 T12.43%
2025 โ‚น2.005 T6.28%
2024 โ‚น1.887 T28.01%
2023 โ‚น1.474 T57.81%
2022 โ‚น934.13 B5.24%
2021 โ‚น887.65 B12.38%
2020 โ‚น789.85 B13.11%
2019 โ‚น698.31 B-3.45%
2018 โ‚น723.26 B1.88%
2017 โ‚น709.89 B4.3%
2016 โ‚น680.60 B10.32%
2015 โ‚น616.92 B7.47%
2014 โ‚น574.06 B3.4%
2013 โ‚น555.18 B19.09%
2012 โ‚น466.19 B15.58%
2011 โ‚น403.36 B16.58%
2010 โ‚น346.00 B25.66%
2009 โ‚น275.36 B10.68%
2008 โ‚น248.79 B55.82%
2007 โ‚น159.67 B7.02%
2006 โ‚น149.19 B19.05%
2005 โ‚น125.32 B10.55%
2004 โ‚น113.35 B
2002 โ‚น78.94 B-14.39%
2001 โ‚น92.20 B-52.82%
2000 โ‚น195.41 B250%
1999 โ‚น55.83 B31.21%
1998 โ‚น42.55 B34.31%
1997 โ‚น31.68 B11.46%
1996 โ‚น28.42 B9.03%
1995 โ‚น26.06 B-3.15%
1994 โ‚น26.91 B-0.67%
1993 โ‚น27.09 B45.38%
1992 โ‚น18.63 B-13.81%
1991 โ‚น21.62 B37.12%
1990 โ‚น15.77 B-0.79%
1989 โ‚น15.89 B26.2%
1988 โ‚น12.59 B24.97%
1987 โ‚น10.07 B-0.9%
1986 โ‚น10.17 B-7.78%
1985 โ‚น11.02 B24.87%
1984 โ‚น8.83 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.013 T-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.978 T 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น732.76 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น918.24 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA